Explore All Access
Check if your research matches the topics covered in PharmacoEconomics - Open?
- Degree of match
- Common matching concepts
- Additional journal recommendations
PharmacoEconomics - Open : Impact Factor & More
eISSN: 2509-4254pISSN: 2509-4262
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
PharmacoEconomics - Open Key Metrics
CiteScore 
2.9
H-Index
17
SJR
Q2Pharmacology
SNIP
0.78
Topics Covered on PharmacoEconomics - Open
Quality of life
Economic evaluation
Randomized controlled trial
Type 2 diabetes
Docetaxel
Total cost
Scenario analysis
Progression-free survival
Point-of-care testing
Cancer therapy
Sensitivity analysis
Health economics
Community-acquired pneumonia
Budget impact
Willingness to pay
Overall survival
Type 2 Diabetes Mellitus
Indirect costs
Uncertainty
Outcomes research
PharmacoEconomics - Open Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2790 | USD 3490 | GBP 2390 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in PharmacoEconomics - Open ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in PharmacoEconomics - Open
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data.
- 6 Dec 2024
- PharmacoEconomics - open
Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India.
- 2 Dec 2024
- PharmacoEconomics - open
Acknowledgement to Referees.
- 29 Nov 2024
- PharmacoEconomics - open
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey.
- 28 Nov 2024
- PharmacoEconomics - open
Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis.
- 23 Nov 2024
- PharmacoEconomics - open
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis.
- 19 Nov 2024
- PharmacoEconomics - open
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data.
- 6 Dec 2024
- PharmacoEconomics - open
Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India.
- 2 Dec 2024
- PharmacoEconomics - open
Acknowledgement to Referees.
- 29 Nov 2024
- PharmacoEconomics - open
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey.
- 28 Nov 2024
- PharmacoEconomics - open
Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis.
- 23 Nov 2024
- PharmacoEconomics - open
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis.
- 19 Nov 2024
- PharmacoEconomics - open
Compare Similar Journals with PharmacoEconomics - Open
Select Journals to Compare with PharmacoEconomics - Open
Total journals - 9
You can select up to 3 Journals at a time
Value in Health
Publisher: ELSEVIER SCIENCE INC
BMJ Open
Publisher: BMJ PUBLISHING GROUP
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
PharmacoEconomics
Publisher: ADIS INT LTD
Journal of Medical Economics
Publisher: TAYLOR & FRANCIS LTD
Expert Review of Pharmacoeconomics and Outcomes Research
Publisher: TAYLOR & FRANCIS LTD
Applied Health Economics and Health Policy
Publisher: SPRINGER INT PUBL AG
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
International Journal of Technology Assessment in Health Care
Publisher: CAMBRIDGE UNIV PRESS
0 Journals Selected to compare with
PharmacoEconomics - Open
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on PharmacoEconomics - Open
How long has PharmacoEconomics - Open been actively publishing? 
PharmacoEconomics - Open has been in operation since 2017 till date.
What is the publishing frequency of PharmacoEconomics - Open?
PharmacoEconomics - Open published with a Quarterly frequency.
How many articles did PharmacoEconomics - Open publish last year?
In 2023, PharmacoEconomics - Open publsihed 77 articles.
What is the eISSN & pISSN for PharmacoEconomics - Open?
For PharmacoEconomics - Open, eISSN is 2509-4254 and pISSN is 2509-4262.
What is Citescore for PharmacoEconomics - Open?
Citescore for PharmacoEconomics - Open is 2.9.
What is the H Index for PharmacoEconomics - Open ?
H Index for PharmacoEconomics - Open is 17.
What is SNIP score for PharmacoEconomics - Open?
SNIP score for PharmacoEconomics - Open is 0.78.
What is the SJR for PharmacoEconomics - Open?
SJR for PharmacoEconomics - Open is Q2.
Who is the publisher of PharmacoEconomics - Open?
SPRINGER INT PUBL AG is the publisher of PharmacoEconomics - Open.
